Sr. Director, Launch Excellence & Operations

Join Immaticsandshape thefuture ofcancerimmunotherapy; one patient at atime!

Immaticsis committed to making a meaningful impact on the lives of patients with cancer. We are the global leader in precision targeting ofPRAME, a target expressed in more than 50 cancers. Our cutting-edge science and robust clinical pipeline form the broadestPRAMEfranchise with the mostPRAMEindications and modalities, spanning TCR T‑cell therapies and TCRbispecifics.

Innovative Environment:
Helptopioneeradvancementsincancer immunotherapy.
Collaborative Culture:

Be part ofa diverse team dedicated to yourprofessionalgrowth.
Global Impact:

Contribute to therapiesthatmakealastingimpactonpatientsglobally.

The Senior Director, Launch Excellence & Operations serves as a strategic partner and deputy to the VP, Launch Excellence, Strategy & Operations, helping shape and execute Immatics' commercial launch strategy. This highly visible role sits at the center of launch planning, governance, and operational readiness, ensuring cross-functional alignment and execution as the organization prepares for commercialization. The successful candidate will lead integrated launch planning, support the Launch Readiness Review (LRR) process, and establish the operating rhythms, governance, and performance management frameworks necessary to drive launch success.

This individual will operate seamlessly between strategy and execution, translating insights into action, guiding critical business decisions, and creating clarity in a dynamic and evolving environment.

Reports to:

Vice President, Launch Excellence, Strategy & Operations

Location:

US, Fully Remote
Salary Range: $250,000 - $290,000

• Bachelor’s degree in life sciences, business, engineering, or a related field with 15+ years of relevant experience OR MBA / advanced degree (MBA, PhD, MD, or equivalent) with 12+ years of relevant experience
• A combination of top-tier strategy consulting experience and in-house biopharmaceutical commercial strategy, commercial operations, or launch leadership experience.

• 5+ years in oncology; direct experience with TCR, CAR‑T, or TIL cell therapies, including a first wave of commercial launch strongly preferred
• Demonstrated ownership of commercial launch strategy or launch readiness — including launch planning, cross‑functional governance, milestone and risk management, and readiness tracking through to launch.
• Knowledge of personalized manufacturing and vein-to‑vein logistics, including manufacturing slot allocation and patient journey management.
• Understanding of the melanoma treatment landscape, therapeutic decision-making, and patient access barriers.
• Working knowledge of the cell therapy operational value chain — treatment center authorization, apheresis scheduling, chain of identity / chain of custody, and product delivery.
• Experience standing up launch governance, a launch readiness review process, or a commercial PMO from scratch.
• Familiarity with digital launch excellence tools and analytics.
• Experience scoping and managing external consultants, agencies, and analytics vendors.
• Proven ability to drive strategic decision‑making across functions without direct authority: framing the decision, assembling the analysis, aligning stakeholders, and driving the issue to closure.
• Exceptional executive communication, influencing, and synthesis skills; able to distill complex, ambiguous cross‑functional situations into a clear recommendation.
• Strong strategic planning and operational execution skills.

• Launch Strategy & Commercial Planning Partner with the VP to develop and execute an integrated launch strategy, roadmap, and commercial playbook.
• Lead strategic evaluations and…